Modafinil-induced reversible hyperkinetic nondystonic movement disorder in a patient with major depressive disorder [5]

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 18, Issue 2, 2006, Pages 248-249

  Luborzewski, Alexander ^a   Regen, Francesca ^a   Schindler, Frank ^a   Anghelescu, Ion ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MODAFINIL; VENLAFAXINE; ZOPICLONE;

AGED; CASE REPORT; CLINICAL FEATURE; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG RESPONSE; DRUG WITHDRAWAL; FATIGUE; FEMALE; FOLLOW UP; HAMILTON ANXIETY SCALE; HOSPITAL DISCHARGE; HUMAN; HYPERKINESIA; INSOMNIA; LASSITUDE; LETTER; MAJOR DEPRESSION; MOTOR DYSFUNCTION; PRIORITY JOURNAL; REMISSION; SYMPTOM;

EID: 33646717170     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.2006.18.2.248     Document Type: Letter

References (5)

1. Fava M, Thase ME, DeBattista C: A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness. J Clin Psychiatry 2005; 66:85-93
2. Ninan PT, Hassman HA, Glass SJ, et al: Adjunctive modafinil at initiation of treatment with a selective serotonin reuptake inhibitor enhances the degree and onset of therapeutic effects in patients with major depressive disorder and fatigue. J Clin Psychiatry 2004; 65:414-420
3. US Modafinil Multicenter Study Group: Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy. Neurology 2000; 54(5):1166-1175
4. Thobois S, Xie J, Mollion H, et al: Adrafinil-induced orofacial dyskinesia. Mov Disord 2004 Aug; 19(8):965-966
5. Kane JM, Woerner M, Lieberman J: Tardive dyskinesia: prevalence, incidence, and risk factors. Psychopharmacology (Berl) Suppl 1985; 2:72-78